Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Cook Medical Contract Gives Access to Health Care Providers through Premier Purchasing Partners to purchase Tissue Repair Produc

Posted Jul 21 2009 10:46pm

Not too long ago I conducted an interview regarding tissue repair and regenerative medicine with Cook Medical and you can read more at the link clip_image003 below about the BioDesign product with Mark Bleyer, President of Cook Biotech and Mike Hiles, Ph.D., VP of Research and Lead Research Scientist at Cook Biotech.

The press release below offers information availability with their new agreement with Premier Purchasing Partners to secure the product for use at medical facilities.  BD

Regenerative Medicine and How it Works – Interview with Cook Biotech (Medical)

Press Release:

60,000 U.S. Health Care Providers Gain Access to Soft-Tissue Repair Technology with New Premier, Cook Medical Agreement

Expanded partnership demonstrates shared commitment to advanced medical technologies, cost-effective biologically based treatments and improved patient care

More than 2,100 U.S. hospitals and 58,000 additional health care providers will now have access to special pricing and terms for a biologically based technology for soft-tissue repair through a contractual relationship between Cook Medical and Premier Purchasing Partners, LP, a national leader in helping to improve the quality and affordability of health care. Under the new agreement, effective July 1, 2009, Cook’s Biodesign™ Advanced Tissue Repair products designed for the surgical treatment of incontinence, will bring a new technology for soft tissue repair to Premier’s extensive base of providers. 

“This contract award is yet another indication that the market is clamoring for a biologically-based tissue repair solution that may deliver better surgical outcomes than synthetic alternatives and an improved quality of life for patients,” said Pete Yonkman, Cook’s executive vice president of sales and marketing. “We look forward to furthering our relationship with Premier to provide advanced patient care throughout its network of non-profit hospitals.”

Cook’s Biodesign line is the fifth product contract with Premier, and specifies four applications for soft tissue repair: continence restoration, fistula image repair, vaginal erosion repair and pelvic-floor reconstruction. Historically, physicians have had just two options for treatment of these conditions: synthetic mesh or biologic grafts. The Biodesign product line offers a new alternative in which the graft communicates with surrounding cells to encourage tissue growth across the scaffold. Biodesign technology combines the best attributes of a biologic graft—resistance to infection and complete remodeling [1] —with the added benefits of moderate price, ease of use and widespread availability. Cook has 22 FDA clearances for its Biodesign technology, which is available in 91 countries and has been used to treat more than one million patients.

About Premier Inc.  
The Premier health care alliance is more than 2,100 U.S. hospitals and 58,000-plus other health care sites working together to improve health care quality and affordability. Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading health care purchasing network. A world leader in helping deliver measurable improvements in care, Premier works with the Centers for

Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Premier has offices in San Diego, Charlotte, N.C., Philadelphia and Washington.

About Cook Medical

Cook Medical was one of the first companies to help popularize interventional medicine, pioneering many of the devices now commonly used worldwide to perform minimally invasive medical procedures. Today, the company integrates minimally invasive medical device design, biopharma, gene and cell therapy, and biotech to enhance patient safety and improve clinical outcomes in the fields of aortic intervention; interventional cardiology; critical care medicine; gastroenterology; radiology , peripheral vascular, bone access and oncology; surgery and soft tissue repair; urology; and assisted reproductive technology, gynecology and high-risk obstetrics. Founded in 1963 and operated as a family-held private corporation, Cook is a winner of the prestigious Medical Device Manufacturer of the Year Award from Medical Device & Diagnostic Industry magazine. For more information, visit www.cookmedical.com.

Related Reading:

Cook Medical Announces FDA Clearance for Advance® 35LP PTA Balloon Dilatation Catheter - PVD

Cook Medical Interview Discussing PAD Leg Therapies– Rob Lyles, VP Peripheral Intervention Division
Post a comment
Write a comment: